Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA "SP-8203-2001"

Active, not recruiting

Phase 2 Results N/A

Summary of Purpose

The current study aims to evaluate the safety of SP-8203, designing in two stages (stage-1, stage-2) to evaluate the safety and efficacy of the combination therapy of SP-8203 and rtPA for the occurrence of cerebral hemorrhage in patients with acute ischemic stroke receiving rtPA standard of care.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 August 2017.

1 May 2016 18 May 2016 1 Jun 2017 1 Dec 2017 1 Jan 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions See All

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment

Contacts

  • Jong Sung Kim, MD, PhD